



Other version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289564/
![]() |
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study |
|
Authors | ![]() | |
Published in | Lancet. 2020, vol. 396, no. 10247, p. 313-319 | |
Abstract | Assessing the burden of COVID-19 on the basis of medically attended case numbers is suboptimal given its reliance on testing strategy, changing case definitions, and disease presentation. Population-based serosurveys measuring anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies provide one method for estimating infection rates and monitoring the progression of the epidemic. Here, we estimate weekly seroprevalence of anti-SARS-CoV-2 antibodies in the population of Geneva, Switzerland, during the epidemic. | |
Keywords | Adolescent — Adult — Age Distribution — Aged — Antibodies — Viral/blood — Betacoronavirus/immunology — Child — Child Preschool — Coronavirus Infections/epidemiology/virology — Female — Humans — Immunoglobulin G/blood — Male — Middle Aged — Pandemics — Pneumonia — Viral/epidemiology/virology — Prevalence — Seroepidemiologic Studies — Sex Distribution — Switzerland/epidemiology — Young Adult | |
Identifiers | PMID: 32534626 | |
Full text |
![]() ![]() ![]() ![]() Other version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289564/ |
|
Structures |
Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique Faculté de médecine / Section de médecine fondamentale / Département de microbiologie et médecine moléculaire |
|
Research groups | Chimie et protéomique clinique (270) Emerging viruses (993) Ethique biomédicale (783) Groupe Flahault Antoine (945) Groupe Laurent Kaiser (virologie clinique) (668) Recherche en infectiologie pédiatrique et en pédiatrie générale (853) Staphylocoques dorés résistants à la méthicilline et hygiène hospitalière (330) | |
Citation (ISO format) | STRINGHINI, Silvia et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. In: The Lancet, 2020, vol. 396, n° 10247, p. 313-319. doi: 10.1016/S0140-6736(20)31304-0 https://archive-ouverte.unige.ch/unige:140135 |